This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A randomized, double-blind, parallel-group study o...
Clinical trial

A randomized, double-blind, parallel-group study of safety and the effect on clinical outcome of tocilizumab SC versus placebo SC in combination with traditional disease modifying anti-rheumatic drugs (DMARDs), in patients with moderate to severe active r

Read time: 1 mins
Last updated:19th Jan 2011
Eficacia del tratamiento con 162 mg de tocilizumab (TCZ) SC frente a placebo administrados cada dos semanas (C2S) en combinaci�n con FAMEs, en la semana 24 utilizando el ACR20.
Category Value
Study start date 2011-01-19

View full details